Cargando…

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

OBJECTIVE: We studied evolving antithrombotic therapy patterns in patients with newly diagnosed non-valvular atrial fibrillation (AF) and ≥1 additional stroke risk factor between 2010 and 2015. METHODS: 39 670 patients were prospectively enrolled in four sequential cohorts in the Global Anticoagulan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camm, A John, Accetta, Gabriele, Ambrosio, Giuseppe, Atar, Dan, Bassand, Jean-Pierre, Berge, Eivind, Cools, Frank, Fitzmaurice, David A, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Kayani, Gloria, Koretsune, Yukihiro, Mantovani, Lorenzo G, Misselwitz, Frank, Oh, Seil, Turpie, Alexander G G, Verheugt, Freek W A, Kakkar, Ajay K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Arrhythmias and Sudden Death
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293840/ https://www.ncbi.nlm.nih.gov/pubmed/27647168 http://dx.doi.org/10.1136/heartjnl-2016-309832

Ejemplares similares

Comparative effectiveness of oral anticoagulants in everyday practice
por: Camm, A John, et al.
Publicado: (2021)

Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants
por: Camm, A John, et al.
Publicado: (2018)

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Opportunistic detection of atrial fibrillation using blood pressure monitors: a systematic review
por: Kane, Sarah A, et al.
Publicado: (2016)

Individual-level income and out-of-hospital cardiac arrest survival in men and women
por: van Dongen, Laura H, et al.
Publicado: (2022)

Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies
por: Fradley, Michael G, et al.
Publicado: (2017)

Comparison of three current sets of electrocardiographic interpretation criteria for use in screening athletes
por: Riding, Nathan R, et al.
Publicado: (2015)

Identifying patients with atrial fibrillation recurrences after two pulmonary vein isolation procedures
por: Mulder, Bart A, et al.
Publicado: (2021)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit
por: Jacobs, Maartje S, et al.
Publicado: (2020)

Arrhythmia prevalence and sudden death risk in adults with the m.3243A>G mitochondrial disorder
por: Bourke, John P, et al.
Publicado: (2022)

Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis
por: Nadarajah, Ramesh, et al.
Publicado: (2022)

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation
por: Frausing, Maria Hee Jung Park, et al.
Publicado: (2023)

Improving CHA(2)DS(2)-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation
por: Graves, Kevin G, et al.
Publicado: (2018)

Sudden Unexpected Death in North Carolina (SUDDEN): methodology review and screening results
por: Nanavati, Parin P, et al.
Publicado: (2014)

Digitally enabled acute care for atrial fibrillation: conception, feasibility and early outcomes of an AF virtual ward
por: Kotb, Ahmed, et al.
Publicado: (2023)

Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registry
por: Blom, M T, et al.
Publicado: (2014)

Low incidence of left atrial delayed enhancement with MRI in patients with AF: a single-centre experience
por: Bois, John P, et al.
Publicado: (2017)

Clinical presentation of CIED infection following initial implant versus reoperation for generator change or lead addition
por: Harper, Mariko W, et al.
Publicado: (2018)

Modifiable risk factors predict incident atrial fibrillation and heart failure
por: Wong, Jorge A, et al.
Publicado: (2020)

Internationally validated score to predict the outcome of non-paroxysmal atrial fibrillation ablation: the ‘FLAME score’
por: Boyalla, Vennela, et al.
Publicado: (2021)

Impact of timing of atrial fibrillation, CHA(2)DS(2)-VASc score and cancer therapeutics on mortality in oncology patients
por: Hussain, Muzna, et al.
Publicado: (2020)

Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy
por: Vijapurapu, Ravi, et al.
Publicado: (2019)

Shift work is associated with 10-year incidence of atrial fibrillation in younger but not older individuals from the general population: results from the Tromsø Study
por: Zwartkruis, Victor W, et al.
Publicado: (2022)

Heart rate is associated with progression of atrial fibrillation, independent of rhythm
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis
por: Emanuel, Subo, et al.
Publicado: (2023)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

Discovery of predictors of sudden cardiac arrest in diabetes: rationale and outline of the RESCUED (REcognition of Sudden Cardiac arrest vUlnErability in Diabetes) project
por: van Dongen, Laura H, et al.
Publicado: (2021)

A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation?
por: Ezzat, Vivienne A, et al.
Publicado: (2015)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010
por: Tiwari, Sweta, et al.
Publicado: (2015)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Implantable loop recorders in patients with heart disease: comparison between patients with and without syncope
por: Assaf, Amira, et al.
Publicado: (2021)

Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease
por: Vijapurapu, Ravi, et al.
Publicado: (2023)

Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
por: Sandhu, Roopinder K, et al.
Publicado: (2018)

Obesity is associated with impaired long-term success of pulmonary vein isolation: a plea for risk factor management before ablation
por: De Maat, Gijs E, et al.
Publicado: (2018)

Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis
por: Gill, Simrat, et al.
Publicado: (2022)

Prospective arrhythmia surveillance after a COVID-19 diagnosis
por: Dewland, Thomas A, et al.
Publicado: (2022)

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials
por: Martin, Ruairidh I R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2b7qqv3fc7666ri1tmjsleufrm